SVP Buckbee sells 18.9K shares of ABBV for $3.9M at $203.40–$203.41; retains 11.5K shares post-transaction
Kevin K Buckbee, SVP and Controller at AbbVie, executed 2 separate sales on 2025-02-26 totaling 18,944 shares for $3,853,372.20, reducing his holdings by 62.2% from 30,440 shares to 11,496 shares. The blended sale price of $203.41 occurred when the stock was trading near its 52-week high of $209.03, though the current price context does not allow attribution of timing to forward-looking conviction. Notably, Buckbee's cross-ticker track record shows 100% well-timed selling at the 90-day mark (with a prior ABBV sale on 2024-02-29 posting a negative 90-day return), but the present filing's timing relative to subsequent price action cannot be assessed at filing date. The company's valuation metrics show a P/E of 81.33 and recent quarterly net income of $1.6B against revenue of $14.5B, representing a moderately profitable large-cap profile.